About this Journal Submit a Manuscript Table of Contents
Journal of Toxicology
Volume 2012 (2012), Article ID 286079, 22 pages
http://dx.doi.org/10.1155/2012/286079
Research Article

Quantitative Property-Property Relationship for Screening-Level Prediction of Intrinsic Clearance of Volatile Organic Chemicals in Rats and Its Integration within PBPK Models to Predict Inhalation Pharmacokinetics in Humans

Département de Santé Environnementale et Santé au Travail, Université de Montréal, C.P. 6128, Succursale Centre-Ville, Montréal, QC, Canada H3C 3J7

Received 31 October 2011; Revised 13 January 2012; Accepted 13 January 2012

Academic Editor: Jane C. Caldwell

Copyright © 2012 Thomas Peyret and Kannan Krishnan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Commission des communautés européennes, LIVRE BLANC Stratégie pour la future politique dans le domaine des substances chimiques, 2001.
  2. CEPA, “Loi canadienne sur la protection de l'environnement (1999), Règlement sur les renseignements concernant les substances nouvelles (substances chimiques et polymères),” in Gazette du Canada partie II, pp. 1850–2221, Queen's Printer for Canada, Ottawa, Canada, 2005.
  3. United States Environmental Protection Agency, “The U.S. Environmental Protection Agency's strategic plan for evaluating the toxicity of chemicals,” Tech. Rep. EPA/100/K-09/001, Office of the Science Advisor, Science Policy Council, Washington, DC, USA, 2009.
  4. K. Krishnan and M. E. Andersen, “Physiologically based pharmacokinetic modeling in toxicology,” in Principles and Methods of Toxicology, A. W. Hayes, Ed., pp. 231–292, Taylor & Francis, Boca Raton, Fla, USA, 2007.
  5. A. D. Arms and C. C. Travis, “Reference physiological parameters in pharmacokinetic modeling,” Tech. Rep. EPA/600/6-88/004, United States Environmental Protection Agency, Washington, DC, USA, 1988.
  6. R. P. Brown, M. D. Delp, S. L. Lindstedt, L. R. Rhomberg, and R. P. Beliles, “Physiological parameter values for physiologically based pharmacokinetic models,” Toxicology and Industrial Health, vol. 13, no. 4, pp. 407–484, 1997. View at Scopus
  7. M. Béliveau and K. Krishnan, “In Silico approaches for developing physiologically based pharmacokinetic (PBPK) models,” in Alternative Toxicological Methods, H. Salem and S. A. Katz, Eds., pp. 479–532, CRC Press, Boca Raton, Fla, USA, 2003.
  8. T. Peyret and K. Krishnan, “QSARs for PBPK modelling of environmental contaminants,” SAR and QSAR in Environmental Research, vol. 22, no. 1-2, pp. 129–169, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J. DeJongh, H. J. M. Verhaar, and J. L. M. Hermens, “A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue blood partition coefficients of organic chemicals in rats and humans,” Archives of Toxicology, vol. 72, no. 1, pp. 17–25, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Poulin and K. Krishnan, “An algorithm for predicting tissue: blood partition coefficients of organic chemicals from n-octanol: water partition coefficient data,” Journal of Toxicology and Environmental Health, vol. 46, no. 1, pp. 117–129, 1995. View at Scopus
  11. P. Poulin and K. Krishnan, “A biologically-based algorithm for predicting human tissue: blood partition coefficients of organic chemicals,” Human and Experimental Toxicology, vol. 14, no. 3, pp. 273–280, 1995. View at Scopus
  12. P. Poulin and K. Krishnan, “A tissue composition-based algorithm for predicting tissue: air partition coefficients of organic chemicals,” Toxicology and Applied Pharmacology, vol. 136, no. 1, pp. 126–130, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Poulin and K. Krishnan, “A mechanistic algorithm for predicting blood: air partition coefficients of organic chemicals with the consideration of reversible binding in hemoglobin,” Toxicology and Applied Pharmacology, vol. 136, no. 1, pp. 131–137, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Poulin and F. P. Theil, “A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery,” Journal of Pharmaceutical Sciences, vol. 89, no. 1, pp. 16–35, 2000.
  15. P. Poulin and F. P. Theil, “Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution,” Journal of Pharmaceutical Sciences, vol. 91, no. 1, pp. 129–156, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Rodgers, D. Leahy, and M. Rowland, “Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases,” Journal of Pharmaceutical Sciences, vol. 94, no. 6, pp. 1259–1276, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Rodgers and M. Rowland, “Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions,” Journal of Pharmaceutical Sciences, vol. 95, no. 6, pp. 1238–1257, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Schmitt, “General approach for the calculation of tissue to plasma partition coefficients,” Toxicology in Vitro, vol. 22, no. 2, pp. 457–467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Peyret, P. Poulin, and K. Krishnan, “A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals,” Toxicology and Applied Pharmacology, vol. 249, no. 3, pp. 197–207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Rydberg, U. Ryde, and L. Olsen, “Prediction of activation energies for aromatic oxidation by cytochrome P450,” Journal of Physical Chemistry A, vol. 112, no. 50, pp. 13058–13065, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Zhou, L. Afzelius, S. W. Grimm, T. B. Andersson, R. J. Zauhar, and I. Zamora, “Comparison of methods for the prediction of the metabolic sites for CYP3A4-mediated metabolic reactions,” Drug Metabolism and Disposition, vol. 34, no. 6, pp. 976–983, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Hansch, S. B. Mekapati, A. Kurup, and R. P. Verma, “QSAR of Cytochrome P450,” Drug Metabolism Reviews, vol. 36, no. 1, pp. 105–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. D. F. V. Lewis, C. Sams, and G. D. Loizou, “A quantitative structure-activity relationship analysis on a series of alkyl benzenes metabolized by human cytochrome P450 2E1,” Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 47–52, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. M. L. Gargas, P. G. Seybold, and M. E. Andersen, “Modeling the tissue solubilities and metabolic rate constant Vmax of halogenated methanes, ethanes, and ethylenes,” Toxicology Letters, vol. 43, no. 1–3, pp. 235–256, 1988. View at Scopus
  25. K. R. Korzekwa, J. P. Jones, and J. R. Gillette, “Theoretical studies on cytochrome P-450 mediated hydroxylation: a predictive model for hydrogen atom abstractions,” Journal of the American Chemical Society, vol. 112, no. 19, pp. 7042–7046, 1990. View at Scopus
  26. H. Yin, M. W. Anders, K. R. Korzekwa et al., “Designing safer chemicals: predicting the rates of metabolism of halogenated alkanes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 24, pp. 11076–11080, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. C. L. Waller, M. V. Evans, and J. D. Mckinney, “Modeling the cytochrome P450-mediated metabolism of chlorinated volatile organic compounds,” Drug Metabolism and Disposition, vol. 24, no. 2, pp. 203–210, 1996. View at Scopus
  28. J. Ishizaki, K. Yokogawa, E. Nakashima, and F. Ichimura, “Relationships between the hepatic intrinsic clearance or blood cell-plasma partition coefficient in the rabbit and the lipophilicity of basic drugs,” Journal of Pharmacy and Pharmacology, vol. 49, no. 8, pp. 768–772, 1997. View at Scopus
  29. D. F. V. Lewis, “Modelling human cytochromes P450 for evaluating drug metabolism: an update,” Drug Metabolism and Drug Interactions, vol. 16, no. 4, pp. 307–324, 2000. View at Scopus
  30. D. F. V. Lewis, “Quantitative structure-activity relationships (QSARs) within the cytochrome P450 system: QSARs describing substrate binding, inhibition and induction of P450s,” Inflammopharmacology, vol. 11, no. 1, pp. 43–73, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. J. P. Jones, M. Mysinger, and K. R. Korzekwa, “Computational models for cytochrome P450: a predictive electronic model for aromatic oxidation and hydrogen atom abstraction,” Drug Metabolism and Disposition, vol. 30, no. 1, pp. 7–12, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. D. F. V. Lewis, “On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics: towards the prediction of human P450 substrate specificity and metabolism,” Biochemical Pharmacology, vol. 60, no. 3, pp. 293–306, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. D. F. V. Lewis, S. Modi, and M. Dickins, “Structure-activity relationship for human cytochrome P450 substrates and inhibitors,” Drug Metabolism Reviews, vol. 34, no. 1-2, pp. 69–82, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. K. V. Balakin, S. Ekins, A. Bugrim et al., “Quantitative structure-metabolism relationship modeling of metabolic N-dealkylation reaction rates,” Drug Metabolism and Disposition, vol. 32, no. 10, pp. 1111–1120, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Ekins, S. Andreyev, A. Ryabov et al., “Computational prediction of human drug metabolism,” Expert Opinion on Drug Metabolism and Toxicology, vol. 1, no. 2, pp. 303–324, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. P. N. D'Yachkov, N. V. Kharchevnikova, A. V. Dmitriev, A. V. Kuznetsov, and V. V. Poroikov, “Quantum chemical simulation of cytochrome P450 catalyzed aromatic oxidation: metabolism, toxicity, and biodegradation of benzene derivatives,” International Journal of Quantum Chemistry, vol. 107, no. 13, pp. 2454–2478, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. G. P. Miller, “Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective,” Expert Opinion on Drug Metabolism and Toxicology, vol. 4, no. 8, pp. 1053–1064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. A. N. Mayeno, J. L. Robinson, R. S. H. Yang, and B. Reisfeld, “Predicting activation enthalpies of cytochrome-P450-mediated hydrogen abstractions. 2. Comparison of semiempirical PM3, SAM1, and AM1 with a density functional theory method,” Journal of Chemical Information and Modeling, vol. 49, no. 7, pp. 1692–1703, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Gao, R. Goind, and H. H. Tabak, “Application of the group contribution method for predicting the toxicity of organic chemicals,” Environmental Toxicology and Chemistry, vol. 11, no. 5, pp. 631–636, 1992. View at Scopus
  40. M. Béliveau, J. Lipscomb, R. Tardif, and K. Krishnan, “Quantitative structure-property relationships for interspecies extrapolation of the inhalation pharmacokinetics of organic chemicals,” Chemical Research in Toxicology, vol. 18, no. 3, pp. 475–485, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Béliveau, R. Tardif, and K. Krishnan, “Quantitative structure-property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats,” Toxicology and Applied Pharmacology, vol. 189, no. 3, pp. 221–232, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Kamgang, T. Peyret, and K. Krishnan, “An integrated QSPR-PBPK modelling approach for in vitro-in vivo extrapolation of pharmacokinetics in rats,” SAR and QSAR in Environmental Research, vol. 19, no. 7-8, pp. 669–680, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Price and K. Krishnan, “An integrated QSAR-PBPK modelling approach for predicting the inhalation toxicokinetics of mixtures of volatile organic chemicals in the rat,” SAR and QSAR in Environmental Research, vol. 22, no. 1-2, pp. 107–128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. W. M. Meylan and P. H. Howard, “Atom/fragment contribution method for estimating octanol-water partition coefficients,” Journal of Pharmaceutical Sciences, vol. 84, no. 1, pp. 83–92, 1995. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Poulin and K. Krishnan, “Molecular structure-based prediction of the toxicokinetics of inhaled vapors in humans,” International Journal of Toxicology, vol. 18, no. 1, pp. 7–18, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Haddad, G. C. Tardif, and R. Tardif, “Development of physiologically based toxicokinetic models for improving the human indoor exposure assessment to water contaminants: trichloroethylene and trihalomethanes,” Journal of Toxicology and Environmental Health A, vol. 69, no. 23, pp. 2095–2136, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Ali and R. Tardif, “Toxicokinetic modeling of the combined exposure to toluene and n-hexane in rats and humans,” Journal of Occupational Health, vol. 41, no. 2, pp. 95–103, 1999. View at Scopus
  48. R. Tardif and G. Charest-Tardif, “The importance of measured end-points in demonstrating the occurrence of interactions: a case study with methylchloroform and m-xylene,” Toxicological Sciences, vol. 49, no. 2, pp. 312–317, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. M. L. Gargas, M. E. Andersen, and H. J. Clewell III, “A physiologically based simulation approach for determining metabolic constants from gas uptake data,” Toxicology and Applied Pharmacology, vol. 86, no. 3, pp. 341–352, 1986. View at Scopus
  50. J. C. Ramsey and M. E. Andersen, “A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans,” Toxicology and Applied Pharmacology, vol. 73, no. 1, pp. 159–175, 1984. View at Scopus
  51. M. L. Gargas, H. J. Clewell III, and M. E. Andersen, “Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways,” Toxicology and Applied Pharmacology, vol. 82, no. 2, pp. 211–223, 1986. View at Scopus
  52. J. G. Filser, G. A. Csanády, B. Denk et al., “Toxicokinetics of isoprene in rodents and humans,” Toxicology, vol. 113, no. 1–3, pp. 278–287, 1996. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Haddad, R. Tardif, G. Charest-Tardif, and K. Krishnan, “Physiological modeling of the toxicokinetic interactions in a quaternary mixture of aromatic hydrocarbons,” Toxicology and Applied Pharmacology, vol. 161, no. 3, pp. 249–257, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. J. G. Filser, R. Schmidbauer, F. Rampf, C. M. Baur, C. Putz, and G. A. Csanady, “Toxicokinetics of inhaled propylene in mouse, rat, and human,” Toxicology and Applied Pharmacology, vol. 169, no. 1, pp. 40–51, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. M. L. Gargas, H. J. Clewell, and M. E. Andersen, “Gas uptake inhalation techniques and the rates of metabolism of chloromethanes, chloroethanes and chloroethylenes in the rat,” Inhalation Toxicology, vol. 2, no. 3, pp. 295–319, 1990.
  56. G. L. Kedderis and S. D. Held, “Prediction of furan pharmacokinetics from hepatocyte studies: comparison of bioactivation and hepatic dosimetry in rats, mice, and humans',” Toxicology and Applied Pharmacology, vol. 140, no. 1, pp. 124–130, 1996. View at Publisher · View at Google Scholar · View at Scopus
  57. R. H. Reitz, M. L. Gargas, A. L. Mendrala, and A. M. Schumann, “In vivo and in vitro studies of perchloroethylene metabolism for physiologically based pharmacokinetic modeling in rats, mice, and humans,” Toxicology and Applied Pharmacology, vol. 136, no. 2, pp. 289–306, 1996. View at Publisher · View at Google Scholar · View at Scopus
  58. R. J. Williams, A. Vinegar, J. N. Mcdougal, A. M. Jarabek, and J. W. Fisher, “Rat to human extrapolation of HCFC-123 kinetics deduced from halothane kinetics: a corollary approach to physiologically based pharmacokinetic modeling,” Fundamental and Applied Toxicology, vol. 30, no. 1, pp. 55–66, 1996. View at Publisher · View at Google Scholar · View at Scopus
  59. G. A. Csanády, B. Denk, C. Pütz et al., “A physiological toxicokinetic model for exogenous and endogenous ethylene and ethylene oxide in rat, mouse, and human: formation of 2- hydroxyethyl adducts with hemoglobin and DNA,” Toxicology and Applied Pharmacology, vol. 165, no. 1, pp. 1–26, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. J. E. Dennison, M. E. Andersen, and R. S. H. Yang, “Characterization of the pharmacokinetics of gasoline using PBPK modeling with a complex mixtures chemical lumping approach,” Inhalation Toxicology, vol. 15, no. 10, pp. 961–986, 2003. View at Scopus
  61. A. M. Hissink, J. Krüse, B. M. Kulig et al., “Model studies for evaluating the neurobehavioral effects of complex hydrocarbon solvents. III. PBPK modeling of white spirit constituents as a tool for integrating animal and human test data,” NeuroToxicology, vol. 28, no. 4, pp. 751–760, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. D. F. V. Lewis, Guide to Cytochromes P450: Structure and Function, Taylor & Francis, London, UK, 2001.
  63. A. I. Archakov and G. I. Bachmanova, Eds., Cytochrome P-450 and Active Oxygen, Taylor & Francis, London, UK, 1990.
  64. Z. Fang, J. Sonner, M. J. Laster et al., “Anesthetic and convulsant properties of aromatic compounds and cycloalkanes: implications for mechanisms of narcosis,” Anesthesia and Analgesia, vol. 83, no. 5, pp. 1097–1104, 1996. View at Publisher · View at Google Scholar · View at Scopus
  65. P. D. Lilly, M. E. Andersen, T. M. Ross, and R. A. Pegram, “Physiologically based estimation of in vivo rates of bromodichloromethane metabolism,” Toxicology, vol. 124, no. 2, pp. 141–152, 1997. View at Publisher · View at Google Scholar · View at Scopus
  66. M. L. Gargas, R. J. Burgess, D. E. Voisard, G. H. Cason, and M. E. Andersen, “Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues,” Toxicology and Applied Pharmacology, vol. 98, no. 1, pp. 87–99, 1989. View at Scopus
  67. R. Tardif, G. Charest-Tardif, J. Brodeur, and K. Krishnan, “Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans,” Toxicology and Applied Pharmacology, vol. 144, no. 1, pp. 120–134, 1997. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Béliveau and K. Krishnan, “Estimation of rat blood: air partition coefficients of volatile organic chemicals using reconstituted mixtures of blood components,” Toxicology Letters, vol. 116, no. 3, pp. 183–188, 2000. View at Publisher · View at Google Scholar · View at Scopus
  69. C. Hansch and L. Zhang, “Quantitative structure-activity relationships of cytochrome P-450,” Drug Metabolism Reviews, vol. 25, no. 1-2, pp. 1–48, 1993. View at Scopus
  70. D. F. V. Lewis and M. Dickins, “Baseline lipophilicity relationships in human cytochromes P450 associated with drug metabolism,” Drug Metabolism Reviews, vol. 35, no. 1, pp. 1–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. D. F. V. Lewis and Y. Ito, “Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity,” Xenobiotica, vol. 39, no. 8, pp. 625–635, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. L. B. Kier, “A shape index from molecular graphs,” Quantitative Structure-Activity Relationships, vol. 4, no. 3, pp. 109–116, 1985. View at Scopus
  73. Organisation for Economic Co-operation and Development, “Guidance document on the validation of (quantitative) structure-activity relationship [(Q)SAR] models,” Tech. Rep., OECD-OCDE, Paris, France, 2007, OECD Environment Health and Safety Publications, Editor.
  74. P. Gramatica, “Principles of QSAR models validation: Internal and external,” QSAR and Combinatorial Science, vol. 26, no. 5, pp. 694–701, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. S. A. Glantz and B. K. Slinker, Primer of Applied Regression and Analysis of Variance, McGraw-Hill, New York, NY, USA, 2nd edition, 2001.
  76. S. Wold, “Validation of QSARs,” Quantitative Structure Activity Relashionship, vol. 10, pp. 191–193, 1991.
  77. C. J. W. Meulenberg and H. P. M. Vijverberg, “Empirical relations predicting human and rat tissue: air partition coefficients of volatile organic compounds,” Toxicology and Applied Pharmacology, vol. 165, no. 3, pp. 206–216, 2000. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Batterman, L. Zhang, S. Wang, and A. Franzblau, “Partition coefficients for the trihalomethanes among blood, urine, water, milk and air,” Science of the Total Environment, vol. 284, no. 1–3, pp. 237–247, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. L. M. da Silva, G. Charest-Tardif, K. Krishnan, and R. Tardif, “Influence of oral administration of a quaternary mixture of trihalomethanes on their blood kinetics in the rat,” Toxicology Letters, vol. 106, no. 1, pp. 49–57, 1999. View at Publisher · View at Google Scholar · View at Scopus
  80. M. E. Andersen, H. J. Clewell, M. L. Gargas, F. A. Smith, and R. H. Reitz, “Physiologically based pharmacokinetics and the risk assessment process for methylene chloride,” Toxicology and Applied Pharmacology, vol. 87, no. 2, pp. 185–205, 1987. View at Scopus
  81. J. C. Ramsey, J. D. Young, R. J. Karbowski, M. B. Chenoweth, L. P. McCarty, and W. H. Braun, “Pharmacokinetics of inhaled styrene in human volunteers,” Toxicology and Applied Pharmacology, vol. 53, no. 1, pp. 54–63, 1980.
  82. M. E. Andersen, H. J. Clewell, M. L. Gargas et al., “Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans,” Toxicology and Applied Pharmacology, vol. 108, no. 1, pp. 14–27, 1991. View at Publisher · View at Google Scholar · View at Scopus
  83. T. M. Cahill, I. Cousins, and D. Mackay, “Development and application of a generalized physiologically based pharmacokinetic model for multiple environmental contaminants,” Environmental Toxicology and Chemistry, vol. 22, no. 1, pp. 26–34, 2003. View at Scopus
  84. International Programme on Chemical Safety, Characterization and Application of Physiologically Based Pharmacokinetic Models in Risk Assessment, International Programme on Chemical Safety, 2010.
  85. C. J. MacKay, L. Campbell, A. M. Samuel, et al., “Behavioral changes during exposure to 1,1,1-trichloroethane: time-course and relationship to blood solvent levels,” American Journal of Industrial Medicine, vol. 11, no. 2, pp. 223–239, 1987.
  86. M. T. D. Cronin and D. Livingstone, Predicting Chemical Toxicity and Fate, CRC Press, Boca Raton, Fla, USA, 2004.
  87. H. Gao and C. Hansch, “QSAR of P450 oxidation: on the value of comparing kcat and km with kcat/km,” Drug Metabolism Reviews, vol. 28, no. 4, pp. 513–526, 1996. View at Scopus
  88. J. P. Jones, K. R. Korzekwa, F. J. Eric, and R. W. Michael, “Predicting the rates and regioselectivity of reactions mediated by the P450 superfamily,” in Methods in Enzymology, pp. 326–335, Academic Press, New York, NY, USA, 1996.
  89. D. L. Harris, J.-Y. Park, L. Gruenke, and L. Waskell, “Theoretical study of the ligand-CYP2B4 complexes: effect of structure on binding free energies and heme spin state,” Proteins, vol. 55, no. 4, pp. 895–914, 2004.
  90. L. Olsen, P. Rydberg, T. H. Rod, and U. Ryde, “Prediction of activation energies for hydrogen abstraction by cytochrome P450,” Journal of Medicinal Chemistry, vol. 49, no. 22, pp. 6489–6499, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. D. N. Kim, K. H. Cho, W. S. Oh et al., “EaMEAD: activation energy prediction of cytochrome p450 mediated metabolism with effective atomic descriptors,” Journal of Chemical Information and Modeling, vol. 49, no. 7, pp. 1643–1654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. Y. Lu, S. Rieth, M. Lohitnavy et al., “Application of PBPK modeling in support of the derivation of toxicity reference values for 1-trichloroethane,” Regulatory Toxicology and Pharmacology, vol. 50, no. 2, pp. 249–260, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. R. H. Reitz, J. N. McDougal, M. W. Himmelstein, R. J. Nolan, and A. M. Schumann, “Physiologically based pharmacokinetic modeling with methylchloroform: implications for interspecies, high dose/low dose, and dose route extrapolations,” Toxicology and Applied Pharmacology, vol. 95, no. 2, pp. 185–199, 1988. View at Scopus
  94. M. H. Wang, D. Wade, L. Chen, S. White, and C. S. Yang, “Probing the active sites of rat and human cytochrome P450 2E1 with alcohols and carboxylic acids,” Archives of Biochemistry and Biophysics, vol. 317, no. 1, pp. 299–304, 1995. View at Publisher · View at Google Scholar · View at Scopus